Signaling pathways involved in PDGF-evoked cellular responses in human RPE cells

Biochemical and Biophysical Research Communications

Volumn 344, Issue 3, 2006, Pages 912-919

  Hollborn, Margrit ^a   Bringmann, Andreas ^a   Faude, Frank ^a   Wiedemann, Peter ^a   Kohen, Leon ^a  

^a UNIVERSITY OF LEIPZIG   (Germany)

Author keywords

Chemotaxis; ERK1 2; p38 MAPK; PDGF stimulation; PI3K; Proliferation; Retinal pigment epithelial cells; VEGF expression

Indexed keywords

PLATELET DERIVED GROWTH FACTOR; VASCULOTROPIN A; VASCULOTROPIN B; VASCULOTROPIN C; VASCULOTROPIN D; VASCULOTROPIN RECEPTOR 2;

ARTICLE; CELL MIGRATION; CELL PROLIFERATION; CONTROLLED STUDY; GENE EXPRESSION; HUMAN; HUMAN CELL; PRIORITY JOURNAL; PROTEIN EXPRESSION; PROTEIN FUNCTION; PROTEIN PHOSPHORYLATION; SIGNAL TRANSDUCTION;

CELL MOVEMENT; CELL PROLIFERATION; CELLS, CULTURED; DOSE-RESPONSE RELATIONSHIP, DRUG; HUMANS; MAP KINASE SIGNALING SYSTEM; PIGMENT EPITHELIUM OF EYE; PLATELET-DERIVED GROWTH FACTOR; SIGNAL TRANSDUCTION; VASCULAR ENDOTHELIAL GROWTH FACTOR A;

EID: 33646134125     PISSN: 0006291X     EISSN: 10902104     Source Type: Journal    
DOI: 10.1016/j.bbrc.2006.03.185     Document Type: Article

References (30)

1. Pastor J.C. Proliferative vitreoretinopathy: an overview. Surv. Ophthalmol. 43 (1998) 3-18
2. Limb G.A., Little B.C., Meager A., Ogilvie J.A., Wolstencroft R.A., Franks W.A., Chignell A.H., and Dumonde D.C. Cytokines in proliferative vitreoretinopathy. Eye 5 (1991) 686-693
3. Wiedemann P. Growth factors in retinal diseases: proliferative vitreoretinopathy, proliferative diabetic retinopathy, and retinal degeneration. Surv. Ophthalmol. 36 (1992) 373-384
4. Campochiaro P.A. Pathogenic mechanisms in proliferative vitreoretinopathy. Arch. Ophthalmol. 115 (1997) 237-241
5. Robbins S.G., Mixon R.N., Wilson D.J., Hart C.E., Robertson J.E., Westra I., Planck S.R., and Rosenbaum J.T. Platelet-derived growth factor ligands and receptors immunolocalized in proliferative retinal diseases. Invest. Ophthalmol. Vis. Sci. 35 (1994) 3649-3663
6. Cassidy L., Barry P., Shaw C., Duffy J., and Kennedy S. Platelet derived growth factor and fibroblast growth factor basic levels in the vitreous of patients with vitreoretinal disorders. Br. J. Ophthalmol. 82 (1998) 181-185
7. Vinores S.A., Henderer J.D., Mahlow J., Chiu C., Derevjanik N.L., Larochelle W., Csaky C., and Campochiaro P.A. Isoforms of platelet-derived growth factor and its receptors in epiretinal membranes: immunolocalization to retinal pigmented epithelial cells. Exp. Eye Res. 60 (1995) 607-619
8. Campochiaro P.A., and Glaser B.M. Platelet-derived growth factor is chemotactic for human retinal pigment epithelial cells. Arch. Ophthalmol. 103 (1985) 576-579
9. Hinton D.R., He S., Graf K., Yang D., Hsueh W.A., Ryan S.J., and Law R.E. Mitogen-activated protein kinase activation mediates PDGF-directed migration of RPE cells. Exp. Cell Res. 239 (1998) 11-15
10. Andrews A., Balciunaite E., Leong F.L., Tallquist M., Soriano P., Refojo M., and Kazlauskas A. Platelet-derived growth factor plays a key role in proliferative vitreoretinopathy. Invest. Ophthalmol. Vis. Sci. 40 (1999) 2683-2689
11. Ikuno Y., Leong F.L., and Kazlauskas A. Attenuation of experimental proliferative vitreoretinopathy by inhibiting the platelet-derived growth factor receptor. Invest. Ophthalmol. Vis. Sci. 41 (2000) 3107-3116
12. Mori K., Gehlbach P., Ando A., Dyer G., Lipinsky E., Chaudhry A.G., Hackett S.F., and Campochiaro P.A. Retina-specific expression of PDGF-B versus PDGF-A: vascular versus nonvascular proliferative retinopathy. Invest. Ophthalmol. Vis. Sci. 43 (2002) 2001-2006
13. Aiello L.P., Pierce E.A., Foley E.D., Takagi H., Chen H., Riddle L., Ferrara N., King G.L., and Smith L.E. Suppression of retinal neovascularization in vivo by inhibition of vascular endothelial growth factor (VEGF) using soluble VEGF-receptor chimeric proteins. Proc. Natl. Acad. Sci. USA 92 (1995) 10457-10461
14. Su C.Y., Chen M.T., Wu W.S., and Wu W.C. Concentration of vascular endothelial growth factor in the subretinal fluid of retinal detachment. J. Ocul. Pharmacol. Ther. 16 (2000) 463-469
15. Ogata N., Nishikawa M., Nishimura T., Mitsuma Y., and Matsumura M. Inverse levels of pigment epithelium-derived factor and vascular endothelial growth factor in the vitreous of eyes with rhegmatogenous retinal detachment and proliferative vitreoretinopathy. Am. J. Ophthalmol. 133 (2002) 851-852
16. Chen Y.S., Hackett S.F., Schoenfeld C.L., Vinores M.A., Vinores S.A., and Campochiaro P.A. Localisation of vascular endothelial growth factor and its receptors to cells of vascular and avascular epiretinal membranes. Br. J. Ophthalmol. 81 (1997) 919-926
17. Hecquet C., Lefevre G., Valtink M., Engelmann K., and Mascarelli F. Activation and role of MAP kinase-dependent pathways in retinal pigment epithelial cells: ERK and RPE cell proliferation. Invest. Ophthalmol. Vis. Sci. 43 (2002) 3091-3098
18. Rosenkranz S., DeMali K.A., Gelderloos J.A., Bazenet C., and Kazlauskas A. Identification of the receptor-associated signaling enzymes that are required for platelet-derived growth factor-AA-dependent chemotaxis and DNA synthesis. J. Biol. Chem. 274 (1999) 28335-28343
19. Ikuno Y., Leong F.L., and Kazlauskas A. PI3K and PLCγ play a central role in experimental PVR. Invest. Ophthalmol. Vis. Sci. 43 (2002) 483-489
20. Rameh L.E., and Cantley L.C. The role of phosphoinositide 3-kinase lipid products in cell function. J. Biol. Chem. 274 (1999) 8347-8350
21. Enzmann V., Kaufmann A., Hollborn M., Wiedemann P., Gemsa D., and Kohen L. Effective chemokines and cytokines in the rejection of human retinal pigment epithelium (RPE) cell graft. Transpl. Immunol. 7 (1999) 9-14
22. Pfaffl M. A new mathematical model for relative quantification in real-time RT-PCR. Nucleic Acids Res. 29 (2001) 2002-2007
23. Campochiaro P.A., Hackett S.F., Vinores S.A., Freund J., Csaky C., LaRochelle W., Henderer J., Johnson M., Rodriguez I.R., Friedman Z., Derevjanik N., and Dooner J. Platelet-derived growth factor is an autocrine growth stimulator in retinal pigmented epithelial cells. J. Cell. Sci. 107 (1994) 2459-2469
24. Nagineni C.N., Kutty V., Detrick B., and Hooks J.J. Expression of PDGF and their receptors in human retinal pigment epithelial cells and fibroblasts: regulation by TGF-β. J. Cell Physiol. 203 (2005) 35-43
25. Adamis A.P., Shima D.T., Yeo K.T., Brown L.F., Berse B., D'Amore P.A., and Folkman J. Synthesis and secretion of vascular permeability factor/vascular endothelial growth factor by human retinal pigment epithelial cells. Biochem. Biophys. Res. Commun. 193 (1993) 631-638
26. Surapisitchat J., Hoefen R.J., Pi X., Yoshizumi M., Yan C., and Berk B.C. Fluid shear stress inhibits TNF-alpha activation of JNK but not ERK1/2 or p38 in human umbilical vein endothelial cells: inhibitory crosstalk among MAPK family members. Proc. Natl. Acad. Sci. USA 98 (2001) 6476-6481
27. Sharma G.D., He J., and Bazan H.E. p38 and ERK1/2 coordinate cellular migration and proliferation in epithelial wound healing: evidence of cross-talk activation between MAP kinase cascades. J. Biol. Chem. 278 (2003) 21989-21997
28. Saika S., Okada Y., Miyamoto T., Yamanaka O., Ohnishi Y., Ooshima A., Liu C.Y., Weng D., and Kao W.W. Role of p38 MAP kinase in regulation of cell migration and proliferation in healing corneal epithelium. Invest. Ophthalmol. Vis. Sci. 45 (2004) 100-109
29. Ikuno Y., and Kazlauskas A. An in vivo gene therapy approach for experimental proliferative vitreoretinopathy using the truncated platelet-derived growth factor alpha receptor. Invest. Ophthalmol. Vis. Sci. 43 (2002) 2406-2411
30. Zheng Y., Ikuno Y., Ohj M., Kusaka S., Jiang R., Cekic O., Sawa M., and Tano Y. Platelet-derived growth factor receptor kinase inhibitor AG1295 and inhibition of experimental proliferative vitreoretinopathy. Jpn. J. Ophthalmol. 47 (2003) 158-165